Finding early signs of dilated cardiomyopathy with AI and mobile screening
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial uses a smartphone app to screen first-degree relatives of people with dilated cardiomyopathy (DCM) for early signs of the condition. It aims to detect heart muscle weakness before symptoms start, so that treatment can begin sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be a first-degree relative (parent, sibling, or child) of someone diagnosed with dilated cardiomyopathy (non-ischemic type)
- You must have access to a smartphone or a tablet with internet or cellular data
- You must not have already been told to have heart screening or been diagnosed with a weak heart muscle
- You must be able to provide verbal consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
This trial uses a heart MRI to measure details in people with dilated cardiomyopathy and reduced pumping strength. It aims to use these MRI findings to better predict your future heart risk and guide care.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
This trial is testing a new way to analyze your heart's electrical signal (ECG) to help doctors find heart problems earlier. It is for people who may have risk factors for heart disease, but are not currently having a heart attack or have had bypass surgery.
This study looks at whether certain antibodies (proteins in your blood) can help predict how dilated cardiomyopathy will progress. By testing your blood, researchers hope to learn more about your condition and find better ways to manage it.
This study looks at people who have been newly diagnosed with heart failure to find rare forms of heart muscle disease (cardiomyopathy) early and start the right treatment. It uses advanced heart imaging (CMR) and requires that you have not had heart problems before.
Hear when a new Dilated Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.